December 19, 2011
News : 2011
Monday, December 19, 2011 at 2:00 PM: “Spinocerebellar Ataxia: Working towards a cure”
Save The Date: Tuesday, January 17, 2012 at 4 p.m. “Human Genomics: From Carcinogenesis To Targeted Therapy”
December 7, 2011 -The Sun Sentinel included a story about the summit which quotes Deborah Barbouth, M.D., and Deborah Wasserman, M.S., of UM’s Victor Center for the Prevention of Jewish Genetic Diseases.
December 6, 2011 – “Genomic Medicine in the Sequencing Age”
November 24, 2011 – Can your genes help dictate a diet that lets you lose weight without cutting calories, and know in advance whether you’d get more benefit from bike riding than from long-distance running? UM researchers are looking into it
Sunday, November 13, 2011 (save the date)
November 4, 2011 – The HIHG’s Ren-Hua Chung, Ph.D., first author of the article was quoted…
Eden R. Martin, Ph.D., professor of human genetics and director of the Center for Genetic Epidemiology and Statistical Genetics at the John P. Hussman Institute for Human Genomics, was awarded a $1.6 million grant by the National Institutes of Health to study genetic differences in ancestry among Hispanics in the U.S.
October 28, 2011 – New research has identified a genetic marker that may identify people at high risk for major depression
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of an important and very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that underlie the development of multiple sclerosis.
The 2011 Alzheimer’s Association Bengt Winblad Lifetime Achievement Award was presented to Margaret A. Pericak-Vance, Ph.D., director of the John P. Hussman Institute for Human Genomics and the Dr. John T. Macdonald Foundation Professor of Human Genomics, during a ceremony at the opening of the Alzheimer’s Association’s annual meeting on July 17.
An internationally recognized researcher of novel drug therapies for neuropsychiatric disorders and epigenetics has joined the Miller School faculty and leadership, bringing his team, his wealth of discovery and his drive to find new treatments for autism, Alzheimer’s, schizophrenia, depression, addiction, Parkinson’s, macular degeneration and other human disorders.
Researchers led by geneticists at the University of Miami Miller School of Medicine have identified a new gene that causes retinitis pigmentosa, a form of blindness, ending one South Florida family’s nearly 20-year search for what caused three of their four children to lose their sight.
With delivery of the latest state-of-the-art next-generation sequencing technology, The John P. Hussman Institute for Human Genomics (HIHG) at the Miller School is now one of the largest facilities in the Southeast for next-generation sequencing (NGS).
A son of physicians and an economist by trade, John P. Hussman, Ph.D., may seem like an unlikely lead author on a paper identifying a new genetic pathway in autism research. But Hussman, father to a 16-year-old boy with autism, applied the same statistical tools he uses to map out complex economic relationships to produce new research findings.